Antiestrogenic potentials of ortho-PCB congeners by single or complex exposure

Archives of Pharmacal Research

Volumn 30, Issue 2, 2007, Pages 199-209

  Seung, Min Oh ^a   Byung, Taek Ryu ^a   Sang, Ki Lee ^b   Kyu, Hyuck Chung ^a  

^a Sungkyunkwan University   (South Korea)

^b National Institute of Scientific Investigation   (South Korea)

Author keywords

Antiestrogenic activity; Aromatase activity; Complex mixture; E screen assay; EROD activity; Ortho PCB congeners

Indexed keywords

EID: 33947188028     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02977695     Document Type: Article

References (58)

1. Arcaro, K. F., O'Keefe, P. W., Yang, Y., Clayton, W., and Gierthy, J. F., Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells. Toxicology, 133, 115-127 (1999).
2. Arnold, S. F., Klotz, D. M., Collins, B. M., Vonier, P. M., Gillette, L. J., and MaLachlan, J. A., Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science, 272, 1489-1492 (1996).
3. Bates, M. N., Hannah, D. J., Buckland, S. J., Taucher, J. A., and van Maanen, T., Chlorinated organic contaminants in breast milk of New Zealand women. Environ. Health Perspect., 102(Suppl 1), 211-217 (1994).
4. Bonefeld-Jørgensen, E. C., Andersen, H. R., Rasmussen, T. H., and Vinggaard, A. M., Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity. Toxicology, 158, 141-153 (2001).
5. Bosveld, A. T., Kennedy, S. W., Seinen, W., and van den Berg, M., Ethoxyresorufin-O-deethylase (EROD) inducing potencies of planar chlorinated aromatic hydrocarbons in primary cultures of hepatocytes from different developmental stage of the chicken, Arch. Toxicol., 71, 746-750 (1997).
6. Bradford, M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254 (1976).
7. Bradlow, H. L., Telang, N. T., Sepkovic, D. W., and Osborne, M. P., 2-Hydroxyestrone: the 'good' estrogen, J. Endocr., 150, s529-s265 (1996).
8. Buchanan, D. L., Ohsako, S., Tohyama, C., Cooke, P. S., and Iguchi, T., Dioxin inhibition of estrogen-induced mouse uterine epithelial mitogenesis involves changes in cyclin and transforming growth factor-beta expression. Toxicol. Sci., 66, 62-68 (2002).
9. Buchanan, D. L., Sato, T., Peterson, R. E., and Cooke, P. S., Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse uterus: critical role of the aryl hydrocarbon receptor in stromal tissue. Toxicol. Sci., 57, 302-311. (2000)
10. Bulger, W. H. and Kupfer, D., Estrogenic activity of pesticides and other xenobiotics on the uterus and male reproductive tract. In: Korach, M., McLachlan, J. A. (eds) Endocrine toxicology. Raven Press, New York, pp 1-33. (1985).
11. Chu, I., Villeneuve, D. C., Yagminas, A., Lecavalier, P., Hakansson, H., Ahlborg, U. G., Valli, V. E., Kennedy, S. W., Bergman, A., Seegal, R. F., and Feeley, M., Toxicity of PCB 77 (3,3′,4,4′-Tetrachlorobiphenyl) and PCB 118 (2,3',4,4',5-Pentachlorobiphenyl) in the rat following subchronic dietary exposure, Fund. Appl. Toxicol., 26, 282-292 (1995).
12. Cogliano, V. J., Assessing the cancer risk from environmental PCBs. Environ. Health Perspect., 106, 317-323 (1998).
13. Dannan, G. A., Porubek, D. J., Netson, S. D., Waxman, D. J., and Guengerish, F. P., 17β-Estradiol 2-and 4-hydroxylation catalyzed by rat hepatic cytochrome P450: roles of individual forms, inductive effects, developmental patterns, and alterations by gonadectomy and hormone replacement, Endocrinology, 118, 1952-1960 (1986).
14. Dewailly, E., Ryan, J. J., Lailberte, C., Bruneau, S., Weber, J. P., Gingras, S., and Carrier, G., Exposure of remote martime populations to coplanar PCBs. Environ. Health Perspect., 102(Suppl 1), 205-209 (1994).
15. Drenth, H. J., Bouwman, C. A., Seinen, W., and Van den Berg, M., Effects of some persistent halogenated environmental contaminants on aromatase (CYP19) activity in the human choriocarcinoma cell line JEG-3. Toxicol. Appl. Pharmacol., 148, 50-55 (1998).
16. Ecobichon, D. J. and MacKenzie, D. O., The uterotrophic activity of commercial and isomerically-pure chlorobiphenyls in the rat, Res. Commun. Chem. Path. Pharmacol., 9, 85-95, (1974).
17. Environmental Health in Europe No. 3. Level of PCBs, PCDDs and PCDFs in human milk. Second round of WHO-coordinated exposure study (1996).
18. Furst, P. C. and Wilmers, K., Human milk as a bioindicator for body burden of PCDDs, PCDFs, organochlorine pesticides, and PCBs. Environ. Health Perspect., 102(Suppl. 1), 187-193 (1994).
19. Gillette, J. S., Hansen, L. G., and Rose, R. L., Metabolic effects of episodic polychlorinated biphenyl (PCB) congeners, Rev. Toxicol. Environ. Toxicol., 4, 129-159 (2002).
20. Graumann, K., Breithofer, A., and Jungbauer, A., Monitoring of estrogen mimics by a recombinant yeast assay: synergy between natural and synthetic compounds? The science of the total environment, 225, 69-79 (1999).
21. Hestermann, E. V., Stegeman, J. J., and Hahn, M. E., Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency, Toxicol. Appl. Pharmacol., 168, 160-172 (2000).
22. Kimbrough, R. D., Polychlorinated biphenyls (PCBs) and human health: an update. Crit. Rev. Toxicol., 25, 133-163 (1995).
23. Korach, K. S., Sarver, P., Chae, K., McLachlan, J. A., and McKinney, J. D., Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: Conformationally restricted structural probes, Mol. Pharmacol., 33, 120-126 (1988).
24. Korach, K. S. Davis, V. L., Curtis, S. W., and Bcchinfuso, W. P., Xenoestrogens and estrogen receptor action, In Thomas, J. A., and Colby, H. D. (Eds.). Endcrine Toxicology, Taylor & Francis, pp. 181-205, (1997).
25. Leece, B., Denomme, M. A., Towner, R., Li, A., Landers, J., and Safe, S., Nonadditive interactive effects of polychlorinated biphenyl congeners in rats: role of the 2,3,7,8-tetrachlorodibenzo-p-dioxin receptor. Canadian Journal of Physiology and Pharmacology, 65, 1908-1912 (1987).
26. Machala, M. and Vondracek, J., Estrogenic activity of xenobiotics. Vet. Med., 43, 311-317 (1998).
27. MaFarland, V. A. and Clarke, J. U., Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ. Health Perspect., 81, 225-239 (1989).
28. Navas, J. M. and Segner, H., Antiestrogenic activity of anthropogenic and natural chemicals. Environ. Sci. Pollut. Res., 5, 75-82 (1998).
29. Oenga, G. N., Spink, D. C., Carpenter, D. O., TCDD and PCBs inhibit breast cancer cell proliferation. Toxicol. in Vitro, 18, 811-819 (2004).
30. Olea, N., Pulgar, R., Perez, P., Olea-Serrano, F., Rivas, A., Novillo-Fertrell, A., Pedraza, V., Soto, A. M., and Sonnenschein, C., Estrogenicity of resin-based composites and sealants used in dentistry. Environ. Health Perspect., 104, 198-305 (1996).
31. Parkinson, A., Robertson, L., and Safe, S., Polychlorinated biphenyls as inducers of hepatic microsomal enzymes: structure-activity rules, Chem. Biol. Interact, 30, 271-285 (1981).
32. Perez, P., Pulgar, R., Olea-Serrano, F., Villalobos, M., Rivas, A., Metzler, M., Pedraza, V., and Olea, N., The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. Environ. Health Perspect., 106, 198-305 (1998).
33. Plíšková, M., Vondráèek, J., Canton, R. F., Nera, J., Koèan, A., Petrík, J., Tronvec, T., Sanderson, T., van den Berg, M., and Machala, M., Impact of polychlorinated biphenyls contamination on estrogenic activity in human male serum. Environ. Health Perspect., 113, 1277-1284 (2005).
34. Porter, W. and Safe, S. H., Estrogenic and antiestrogenic compounds, In Puga, A., and Wallace, K.B. (Eds.). Molecular biology of the toxic response. Talylor & Francis, pp. 269-279, (1999).
35. Safe, S., Astroff, B., Harris, M., Zacharewski, T., Dickerson, R., Romkes, M., and Biegel, L. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens: characterization and mechanisms of action. Pharmacol. Toxicol., 69, 400-409 (1991).
36. Safe, S., Polychlorinated biphenyls (PCBs): Environmental impact, biological and toxic responses, and implications for risk assessment. Critical Reviews in Toxicology, 24, 87-149 (1994a).
37. Safe, S. Dietary and environmental estrogens and antiestrogens and their possible role in human disease. Environ. Sci. Pollut. Res., 1, 29-33 (1994b).
38. Safe, S., Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacology and Therapeutics, 67, 247-281 (1995).
39. Safe, S., Limitations of the toxic equivalency factor approach for risk assessment of TCDD and related compounds, Teratog. Carcinog. Mutagen., 17, 285-304 (1997).
40. Safe, S., Interactions between hormone and chemicals in breast cancer. Annu. Rev. Pharmacol. Toxicol., 38, 121-158 (1998).
41. Safe, S. and Wörmke, M., Inhibitory arylhydrocarbon receptor-estrogen receptor a cross-talk and mechanisms of action. Chemical Research in toxicology, 16, 807-816 (2003).
42. Schmitz, H.-J., Hagenmaier, A., Hagenmaier, H.-P., Bock, K. W., and Schrenk, D., Potency of mixtures of polychlorinated biphenyls as inducers of dioxin receptor-regulated CYP1A activity in rat hepatocytes and H4IIE cells. Toxicology, 99, 47-54 (1995).
43. Schneider, J., Huh, M. M., Bradlow, H. L., and Fishman J., Antiestrogenic action of 2-hydroxyestrone on MCF-7 human breast cancer cells, Journal of Biological Chemistry, 259, 4840-4845 (1984).
44. Shou, M., Korzekwa, K. R., Brooks, E. N., Krausz, K. W., Gonzalez, F. J., and Gelboin, H. V., Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone, Carcinogenesis, 18, 207-214 (1997).
45. Simpson, E. R., Mahendroo, M. S., Means, G. D., Kilgore, M. W., Hinshelwood, M. M., Graham-Lorence, S., Amarneh, B., Ito, Y., Fischer, C. R., Michael, M. D., Mendelson, C. R., and Bulun, S. E., Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Reviews, 15, 342-355 (1994).
46. Skehan, P., Storeng, R., Scudiero, D., Monk, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenny, S., and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute, 82, 1107-1112 (1990).
47. Smeets, J. M. W., van Holsteijn, I., Giesy, J. P., and van den Berg, M., The anti-estrogenicity of Ah receptor agonists in Carp (Cyprinus carpio) hepatocytes. Toxicological Sciences, 52, 178-188 (1999).
48. Soto, A. M., Sonnenschein, C., Chung, K. L., Fernandez, M. F., Olea, N., and Serrano, F. O., The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environmental Health Perspectives, 103(suppl 71), 113-122 (1995).
49. nd, Schuetz, J. D., Schuetz, E. G., Johnson, J. A., Kaminsky, L. S., and Gierthy, J. F., 17 Beta-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenz-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA, Arch. Biochem. Biophys., 293, 342-348 (1992).
50. Stancel, G. M., Boettger-Tong, H., Chiappetta, C., Hyder, S. M., Kirkland, J. L., Murthy, L., and Loose-Mitchell, D. S., Toxicology of estrogens and environmental estrogens: what is the role of elemental interactions. Environ. Health Perspect., 103(Suppl 7), 29-33 (1995).
51. Suchar, L. A., Chang, R. L., Rosen, R. T., Lech, J., and Conney, A. H., High performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats. Journal of Pharmacology and Experimental Therapeutics, 272, 197-206 (1995).
52. Suh, J., Kang, J. S., Yang, K. H., and Kaminski, N. E., Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-ortho-substituted polychlorinated biphenyls. Toxicol. Appl. Pharmacol., 187, 11-21 (2003).
53. Tsuchiya, Y., Nakajima, M., and Yokoi, T., Cytochrome P450-mediated metabolism of estrogens and its regulation in human, Cancer Lett., 227, 115-124 (2005).
54. Vakharia, D. D. and Gierthy, J. F., Use of a combined human liver microsome-estrogen receptor binding assay to assess potential estrogen modulating activity of PCB metabolites. Toxicology Lett., 114, 55-65 (2000).
55. Woodhouse, A. and Cooke, G. M., Suppression of aromatase activity in vitro by PCBs 28 and 105 and Arochlor 1221, Toxicology Lett., 152, 91-100 (2004).
56. Yamazaki, H., Shaw, P. W., Guengerich, F. P., and Shimada T., Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes, Chem. Res. Toxicol., 11, 659-665 (1998).
57. Yoo, Y. C., Lee, S. K., Lee, S. Y., Yang, J. Y., In, S. W., Kim, K. W., and Chung, K. H., Distribution of organochlorines pesticides in Korean human tissue. Yakhak Hoeji, 45, 366-377 (2002).
58. Zacharewski, T., Harris, M., and Safe, S., Evidence for the mechanism of action of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decrease of nuclear estrogen receptor levels in wild-type and mutant mouse heap 1c1c7 cells. Biochem. Pharmacol., 41, 1931-1939 (1991).